Plants Genic Profile
Key Indicators
- Authorised Capital ₹ 1.14 Cr
- Paid Up Capital ₹ 1.14 Cr
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.01 Cr
- Revenue Growth %
- Profit Growth -2063.02%
- Ebitda -2113.81%
- Net Worth 16850.06%
- Total Assets 378.62%
About Plants Genic
Plants Genic Private Limited (PGPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 October 2020 (Four years and four months 4 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.14 Cr and a paid-up capital of Rs 1.14 Cr.
The company currently has active open charges totaling ₹3.01 Cr.
Rajendra Agrawal, Neera Agrawal, and Ark Agrawal serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24239MP2020PTC053215
-
Company No.
053215
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Oct 2020
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Plants Genic?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Agrawal
|
Director | 12-Oct-2020 | Current |
|
Ark Agrawal
|
Director | 06-May-2024 | Current |
|
Neera Agrawal
|
Director | 12-Oct-2020 | Current |
Financial Performance of Plants Genic.
Plants Genic Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 2063.02% decrease in profit. The company's net worth Soared by an impressive increase of 16850.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plants Genic?
In 2021, Plants Genic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Parag Copigraph Private LimitedRajendra Agrawal, Neera Agrawal and 1 more are mutual person
Charges (Loans)
₹3.01 Cr
₹0
Charges Breakdown by Lending Institutions
- Sidbi : 3.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Oct 2023 | Sidbi | ₹3.60 M | Open |
| 25 Oct 2021 | Sidbi | ₹2.65 Cr | Open |
How Many Employees Work at Plants Genic?
Plants Genic has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plants Genic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plants Genic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.